Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. CDC director: BA.5 estimated to represent 65% of circulating COVID-19 variants

Published 07/12/2022, 10:31 AM
Updated 07/12/2022, 10:36 AM
© Reuters. Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky gives her opening statement during the Senate Health, Education, Labor and Pensions hearing on "Next Steps: The Road Ahead for the COVID-19 Response" on Capitol Hill in Washington

WASHINGTON (Reuters) - The fast-spreading BA.5 sub-lineage of Omicron is estimated to make up 65% of the coronavirus variants in the United States as of last week, U.S. Centers for Disease Control and Prevention Director Rochelle Walensky said on Tuesday.

The BA.5 and BA.4 variants together accounted for more than 80% of circulating variants last week, with BA.4 making up 16 %, Walensky told reporters at a White House briefing, adding that the seven-day average of COVID-19 hospital admissions has doubled since early May.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.